Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

ChatGPT's medical advice may be deterring women from necessary imaging
The LLM’s responses can be misleading in certain situations, which could be problematic for patients who trust the medical advice it provides.
Tau tangles on PET scans may signal impending cognitive decline in asymptomatic individuals
New data highlight the significance of tau-positive imaging in the progression of Alzheimer’s disease.
Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population
By identifying these structural changes prior to the onset of symptomatic neurodegeneration, providers may be able to initiate preventive therapies sooner.
Bristol Myers Squibb will pay $350M-plus to add prostate cancer imaging agent
Subsidiary RayzeBio has inked a definitive deal to license the worldwide rights for the drug from Philochem, a Swiss biotechnology firm.
FDA issues recall of Philips interventional imaging system due to safety risks
A communication error within the system can reportedly cause loss of imaging functionality mid-procedure.

Alzheimer's therapy enters phase IIa clinical trial

New York City-based Anavex Life Sciences has developed an investigational treatment for Alzheimer's called Anavex 2-73, and announced Nov. 7 that the company would be working with Neuronetrix to take the drug through a phase IIa clinical trial.

Preclinical cancer therapy leads to shrinking neuroblastoma

A cell protein known as MYCN (v-myc avian myelocytomatosis oncogene), one of a group of proteins that spur cellular proliferation, is known to be very resistant to even targeted drug treatments, but preclinical research is turning this protein on itself to fight off new neuroblastoma cancer growth, the Dana Farber Cancer Center and Boston Children’s Hospital announced today.

Molecule could identify and aid treatment of aggressive breast cancers

A molecule has been found that could be leveraged to treat the most dangerous cancers of the breast, known as triple negative breast cancer, according to a Nov. 3 announcement from the City College of New York (CCNY).

Grappling with the genomics of Ebola

Researchers are struggling to lock in genetic analysis related to the genetic mutability of Ebola due to delayed and incomplete data from around the world, according to a review published online today in Science.

Brain DNA methylation in key genes linked to Alzheimer’s

The methylation cycles of several genetic variants—28 in fact—are associated with the hallmark neurodegeneration involved in Alzheimer’s disease (AD). Some variants were found to be associated with amyloid load and others with taupathy, according to a study published online Nov. 3 in JAMA Neurology.

FDG PET superior to SPECT for telling Alzheimer’s from DLB

Dementia imaging with FDG PET was more accurate, sensitive and specific in a comparison between Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB), according to a study published online Nov. 5 in the Journal of Nuclear Medicine.

Definiens acquired by AstraZeneca and MedImmune

Global biologics company AstraZeneca and its research and development division, MedImmune, announced yesterday that the company has acquired Definiens, a biotech firm focusing on imaging and research analysis.

U.K. to gain a major brain imaging center

Cardiff University in Wales has broken ground on a $70 million brain imaging center expected to be "unique within Europe." A range of brain mapping techniques will be implemented to improve researchers' understanding of diseases like multiple schlerosis, schizophrenia and dementia.

Medical Imaging

ChatGPT's medical advice may be deterring women from necessary imaging

Tau tangles on PET scans may signal impending cognitive decline in asymptomatic individuals

Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population

Bristol Myers Squibb will pay $350M-plus to add prostate cancer imaging agent

FDA issues recall of Philips interventional imaging system due to safety risks